Trodelvy showed fewer severe side effects, such as neutropenia and diarrhea, compared to chemotherapy in untreated TNBC ...

Vitamin B6 deficiency symptoms include mood changes, mouth sores, skin lesions, nerve damage, loss of muscle control, seizures, and more.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the ...

T-DXd regimens improved pathologic complete response and safety profiles compared to ddAC-THP in high-risk, HER2-positive early breast cancer. Patient-reported outcomes showed better physical ...

Chemotherapy-induced peripheral neuropathy (CIPN) affects cancer survivors, impacting quality of life. Podiatry care can help manage symptoms and complications.

J&J has received the US FDA approval for Rybrevant Faspro, a SC administered therapy to treat patients with EGFR-mutated ...

Patients with HER2-positive, hormone receptor (HR)-positive metastatic breast cancer can be safely treated without chemotherapy.

This week, Bobbi Conner talks with Dr. Katie Schmitt about oncology physical therapy. Dr. Schmitt is a Doctor of Physical Therapy and a clinical specialist in oncologic physical therapy and certified ...

Downstairs on a Wednesday afternoon, you'll find the entire basement of Peak Pickleball filled with players, some more ...

Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.

MediciNova (MNOV) completed patient enrollment in the Phase 2 clinical trial, the OXTOX study – Oxaliplatin Neurotoxicity study in patients with metastatic colorectal cancer -. This study is ...